๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dendritic cells hold promise for immunotherapy

โœ Scribed by Giampiero Girolomoni; Paola Ricciardi-Castagnoli

Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
234 KB
Volume
18
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dendritic Cells and Immunotherapy for Ca
Dendritic Cells and Immunotherapy for Cancer
โœ David H. Chang; Madhav V. Dhodapkar ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Carden Jennings Publishing ๐ŸŒ English โš– 83 KB
Exploiting dendritic cells for cancer im
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells
โœ Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 579 KB

## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective

Immunotherapy with dendritic cells for p
Immunotherapy with dendritic cells for prostate cancer
โœ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i